Postantibiotic leukocyte enhancement of meropenem against gram-positive and gram-negative strains

A Novelli1, S Fallani, M I Cassetta

  • 1Dipartimento di Farmacologia Preclinica e Clinica, Università degli Studi di Firenze, Florence, Italy. novelli@server1.pharm.unifi.it

Insights

Meropenem demonstrated a stronger postantibiotic effect on leukocyte enhancement (PALE) than imipenem against common bacteria. This suggests meropenem may be more effective in boosting immune cell activity after antibiotic exposure.

Area of Science:

  • Microbiology
  • Immunology
  • Pharmacology

Background:

  • The postantibiotic effect (PAE) describes the suppression of bacterial growth after antibiotic exposure.
  • Leukocyte enhancement is a critical component of the host immune response to bacterial infections.

Purpose of the Study:

  • To compare the postantibiotic leukocyte enhancement (PALE) of meropenem and imipenem in vitro.
  • To evaluate the impact of carbapenem pre-exposure on polymorphonuclear cell (PMN) phagocytic activity.

Main Methods:

  • In vitro evaluation of meropenem and imipenem.
  • Exposure of 24 Gram-positive and Gram-negative bacterial strains to carbapenems at four times the minimum inhibitory concentration (MIC) for 2 hours.
  • Assessment of subsequent polymorphonuclear cell phagocytic killing.

Main Results:

  • Pre-exposure to carbapenems generally enhanced polymorphonuclear cell phagocytic killing.
  • Meropenem exhibited a significantly greater PALE compared to imipenem across tested bacterial strains.

Conclusions:

  • Meropenem shows superior efficacy in enhancing leukocyte function post-exposure compared to imipenem.
  • These findings highlight potential differences in the immunomodulatory effects of carbapenems, with implications for infection treatment strategies.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Antibiotic Selection01:45

Antibiotic Selection

Researchers use antibiotic resistance genes to identify bacteria that possess a plasmid containing their gene of interest. Antibiotic resistance naturally occurs when a spontaneous DNA mutation creates changes in bacterial genes that eliminate antibiotic activity. Bacteria can share these new resistance genes with their offspring and other bacteria. The overuse and misuse of antibiotics have created a public health crisis, as resistant and multi-resistant bacteria continue to develop.Antibiotic...